Aurobindo Pharma Limited (NSE: AUROPHARMA)
India
· Delayed Price · Currency is INR 1,225.00
+5.00 (0.41%)
Nov 22, 2024, 2:18 PM IST
Aurobindo Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 35,816 | 31,730 | 19,275 | 26,482 | 53,348 | 28,451 | Upgrade
|
| Depreciation & Amortization | 14,818 | 14,394 | 11,962 | 10,833 | 10,554 | 9,632 | Upgrade
|
| Other Amortization | 525.2 | 525.2 | 413.1 | 432.4 | - | 35 | Upgrade
|
| Loss (Gain) From Sale of Assets | -290.8 | -234.9 | -132.3 | 1,558 | -31,084 | 370.4 | Upgrade
|
| Asset Writedown & Restructuring Costs | 623.7 | 623.7 | 309.9 | -396.3 | 4,349 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -54.8 | -1 | - | -264.3 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 163.3 | 171.5 | 116.7 | 312.5 | 553.6 | 151.7 | Upgrade
|
| Provision & Write-off of Bad Debts | 213.9 | 232.8 | 524.5 | -61.1 | -291.2 | 685.3 | Upgrade
|
| Other Operating Activities | -3,276 | -6,345 | 2,348 | -4,309 | 6,527 | 1,408 | Upgrade
|
| Change in Accounts Receivable | -7,818 | -2,642 | -4,321 | -4,108 | 7,440 | -6,561 | Upgrade
|
| Change in Inventory | -11,562 | -13,037 | -9,267 | 14,975 | -16,217 | -5,270 | Upgrade
|
| Change in Accounts Payable | -940.8 | 5,828 | 7,077 | 1,107 | 1,265 | 2,959 | Upgrade
|
| Change in Other Net Operating Assets | -12,352 | -6,900 | -4,438 | 3,605 | -3,155 | 11,951 | Upgrade
|
| Operating Cash Flow | 15,867 | 24,345 | 23,868 | 50,165 | 33,291 | 43,813 | Upgrade
|
| Operating Cash Flow Growth | -20.45% | 2.00% | -52.42% | 50.69% | -24.02% | 165.38% | Upgrade
|
| Capital Expenditures | -20,819 | -27,803 | -24,038 | -20,529 | -14,379 | -13,828 | Upgrade
|
| Sale of Property, Plant & Equipment | 820.5 | 602.8 | 110.9 | 3,809 | 481.7 | 190 | Upgrade
|
| Cash Acquisitions | -121.5 | - | -1,970 | -5,814 | -2,742 | 103.5 | Upgrade
|
| Divestitures | - | - | - | 43.2 | 31,739 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2,808 | -7,812 | -3,166 | -6,517 | -4,359 | -483.4 | Upgrade
|
| Investment in Securities | 989.8 | 1,535 | 4,428 | -3,361 | -4,674 | -1,877 | Upgrade
|
| Other Investing Activities | 2,909 | -9,082 | -15,142 | 252.6 | -79.6 | 217.8 | Upgrade
|
| Investing Cash Flow | -19,029 | -42,560 | -39,778 | -32,116 | 5,987 | -15,676 | Upgrade
|
| Short-Term Debt Issued | - | - | 20,697 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 15,632 | 3,936 | 827.3 | 1,770 | - | Upgrade
|
| Total Debt Issued | 19,020 | 15,632 | 24,633 | 827.3 | 1,770 | - | Upgrade
|
| Short-Term Debt Repaid | - | -847.6 | - | -26,367 | -6,678 | -13,130 | Upgrade
|
| Long-Term Debt Repaid | - | -1,638 | -981.2 | -1,331 | -5,904 | -3,194 | Upgrade
|
| Total Debt Repaid | -3,077 | -2,485 | -981.2 | -27,698 | -12,583 | -16,324 | Upgrade
|
| Net Debt Issued (Repaid) | 15,943 | 13,147 | 23,651 | -26,871 | -10,813 | -16,324 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 1.9 | Upgrade
|
| Common Dividends Paid | -2,643 | -2,636 | -4,395 | -2,637 | -2,343 | -1,756 | Upgrade
|
| Other Financing Activities | -3,467 | -2,507 | -1,112 | -185 | -493.5 | -1,394 | Upgrade
|
| Financing Cash Flow | 530.1 | 8,004 | 18,144 | -29,693 | -13,649 | -19,472 | Upgrade
|
| Foreign Exchange Rate Adjustments | 300.1 | 141.7 | -0.6 | 2 | -21.2 | 47.8 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 6.6 | - | 64.1 | -32.5 | 224.1 | - | Upgrade
|
| Net Cash Flow | -2,326 | -10,068 | 2,298 | -11,674 | 25,831 | 8,712 | Upgrade
|
| Free Cash Flow | -4,952 | -3,458 | -170.5 | 29,636 | 18,911 | 29,985 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 56.71% | -36.93% | 1230.96% | Upgrade
|
| Free Cash Flow Margin | -1.63% | -1.19% | -0.07% | 12.63% | 7.63% | 12.98% | Upgrade
|
| Free Cash Flow Per Share | -8.48 | -5.90 | -0.29 | 50.58 | 32.27 | 51.17 | Upgrade
|
| Cash Interest Paid | 3,467 | 2,507 | 1,112 | 185 | 493.5 | 1,266 | Upgrade
|
| Cash Income Tax Paid | 18,781 | 17,666 | 7,172 | 12,582 | 12,853 | 7,736 | Upgrade
|
| Levered Free Cash Flow | -11,766 | -12,590 | -4,803 | 12,129 | 13,662 | 21,013 | Upgrade
|
| Unlevered Free Cash Flow | -9,471 | -10,914 | -3,997 | 12,359 | 14,035 | 22,807 | Upgrade
|
| Change in Net Working Capital | 32,403 | 17,754 | 4,810 | -7,475 | 5,702 | -2,825 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.